Brief: United Therapeutics Says Co Filed Motion In US District Court For Preliminary Injunction In Patent Litigation With Liquidia Technologies
27/02/2024 11:29
Feb 27 (Reuters) - United Therapeutics Corp UTHR.O :
* UNITED THERAPEUTICS- ON FEB 26 CO FILED MOTION IN U.S.
DISTRICT COURT FOR PRELIMINARY INJUNCTION IN PATENT LITIGATION
WITH LIQUIDIA TECHNOLOGIES
* UNITED THERAPEUTICS - CO ASKED COURT TO ENJOIN LIQUIDIA
FROM
MARKETING PRODUCT FOR PH-ILD UNTIL COURT ADJUDICATES CO'S
INFRINGEMENT CLAIMS
Source text for Eikon: ID:n0001104659-24-027791
Further company coverage: UTHR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on United Therapeutics
See all newsBrief: United Therapeutics Corporation Announces Additional $2 Billion Share Repurchase Authorization
Brief: United Therapeutics Announces FDA Clearance To Proceed With Summit Clinical Trial For Treprostinil Smi In Ph-Copd
Liquidia surges as United Therapeutics settlement removes key litigation risk (updated)
Brief: United Therapeutics Enters Settlement Agreement With Liquidia To Resolve Litigation - SEC Filing
Liquidia surges after $381 million settlement with United Therapeutics for lung disease drug